Back

The clinical experience of J valve transapical transcatheter aortic valve replacement system in high-risk patients with severe pure aortic regurgitation

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Non-coronary cardiac intervention Aortic Valve Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Wei Liu

Beijing Jishuitan Hospital, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Comparative evaluation of risk model performance for prediction of 30-day mortality in transcatheter aortic valve replacement
Mr G. Wolff (Ibbenbüren, DE)
Abstract
Presentation thumbnail
Clinical implications of physical function and resilience in patients undergoing transcatheter aortic valve implantation
Doctor B. Lindman (Nashville, US)
Abstract Slides
Presentation thumbnail
Multiple and posterior location of moderate paravalvular leaks are associated with worse long-term outcome after successful TAVR
Doctor L. Kalinczuk (Warsaw, PL)
Abstract
Presentation thumbnail
Percutaneous mitral edge-to-edge valvuloplasty in end-stage heart failure as a bridge to heart transplant: a case series from a single tertiary referral center.
Doctor C. Montalto (Milan, IT)
Abstract Slides
Presentation thumbnail
Risk calculator for prediction of iatrogenic atrial septal defect persistence following percutaneous mitral valve repair
Doctor O. Maier (Duesseldorf, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Non-coronary cardiac intervention

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Correlations with anatomic specimens
thumbnail
Congress Presentation
Aortic regurgitation and stenosis: diagnosis and mode of intervention
thumbnail
Congress Session
Failing valves and beyond

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources